NVO vs. KKR
NVO (Novo Nordisk A/S) and KKR (KKR & Co. Inc.) are both stocks. NVO operates in Drug Manufacturers - General (Healthcare), while KKR operates in Asset Management (Financial Services). Over the past 10 years, NVO returned 8.17%/yr vs 23.95%/yr for KKR. At a 0.27 correlation, their price movements are largely independent.
Performance
NVO vs. KKR - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NVO achieves a -1.67% return, which is significantly higher than KKR's -29.76% return. Over the past 10 years, NVO has underperformed KKR with an annualized return of 8.17%, while KKR has yielded a comparatively higher 23.95% annualized return.
NVO
- 1D
- 0.56%
- 1M
- 6.06%
- YTD
- -1.67%
- 6M
- -2.80%
- 1Y
- -26.15%
- 3Y*
- -13.58%
- 5Y*
- 5.11%
- 10Y*
- 8.17%
KKR
- 1D
- -1.32%
- 1M
- -7.02%
- YTD
- -29.76%
- 6M
- -30.81%
- 1Y
- -33.13%
- 3Y*
- 17.61%
- 5Y*
- 9.45%
- 10Y*
- 23.95%
NVO vs. KKR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NVO Novo Nordisk A/S | -1.67% | -39.22% | -15.93% | 54.84% | 22.66% | 63.52% | 23.33% | 28.70% | -12.98% | 52.92% |
KKR KKR & Co. Inc. | -29.76% | -13.32% | 79.65% | 80.48% | -36.98% | 85.76% | 41.13% | 51.57% | -4.28% | 41.78% |
Correlation
The correlation between NVO and KKR is 0.28, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.28 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.25 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.28 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.25 |
Correlation (All Time) Calculated using the full available price history since Jul 15, 2010 | 0.27 |
Fundamentals
NVO:
$215.05B
KKR:
$84.87B
NVO:
DKK 27.42
KKR:
$3.10
NVO:
11.57
KKR:
28.67
NVO:
0.50
KKR:
3.02
NVO:
4.30
KKR:
4.25
NVO:
6.95
KKR:
1.05
NVO:
DKK 327.80B
KKR:
$19.99B
NVO:
DKK 268.30B
KKR:
$8.35B
NVO:
DKK 181.54B
KKR:
$9.97B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NVO vs. KKR — Risk / Return Rank
NVO
KKR
NVO vs. KKR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Novo Nordisk A/S (NVO) and KKR & Co. Inc. (KKR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NVO | KKR | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.39 | ||
| Sortino ratioReturn per unit of downside risk | +0.78 | ||
| Omega ratioGain probability vs. loss probability | 0.94 | 0.86 | +0.08 |
| Calmar ratioReturn relative to maximum drawdown | -0.53 | -0.74 | +0.21 |
| Martin ratioReturn relative to average drawdown | -0.84 | -1.29 | +0.45 |
Loading charts...
Drawdowns
NVO vs. KKR - Drawdown Comparison
The maximum NVO drawdown since its inception was -74.70%, which is greater than KKR's maximum drawdown of -53.10%. Use the drawdown chart below to compare losses from any high point for NVO and KKR.
Loading charts...
Drawdown Indicators
| NVO | KKR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -74.70% | -53.10% | -21.60% |
Max Drawdown (1Y)Largest decline over 1 year | -49.17% | -44.62% | -4.55% |
Max Drawdown (3Y)Largest decline over 3 years | -74.70% | -49.42% | -25.28% |
Max Drawdown (5Y)Largest decline over 5 years | -74.70% | -49.42% | -25.28% |
Max Drawdown (10Y)Largest decline over 10 years | -74.70% | -49.42% | -25.28% |
Current DrawdownCurrent decline from peak | -64.87% | -46.10% | -18.77% |
Average DrawdownAverage peak-to-trough decline | -17.83% | -16.28% | -1.55% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 31.10% | 25.75% | +5.35% |
Volatility
NVO vs. KKR - Volatility Comparison
Novo Nordisk A/S (NVO) has a higher volatility of 11.68% compared to KKR & Co. Inc. (KKR) at 10.34%. This indicates that NVO's price experiences larger fluctuations and is considered to be riskier than KKR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NVO | KKR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.68% | 10.34% | +1.34% |
Volatility (6M)Calculated over the trailing 6-month period | 37.71% | 29.47% | +8.24% |
Volatility (1Y)Calculated over the trailing 1-year period | 51.65% | 37.19% | +14.46% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 38.48% | 39.29% | -0.81% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 32.57% | 36.56% | -3.99% |
Dividends
NVO vs. KKR - Dividend Comparison
NVO's dividend yield for the trailing twelve months is around 3.73%, more than KKR's 1.17% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
KKR KKR & Co. Inc. | 1.17% | 0.57% | 0.47% | 0.78% | 1.31% | 0.77% | 1.31% | 1.71% | 3.23% | 3.18% | 4.16% | 10.13% |
NVO Novo Nordisk A/S | 3.73% | 3.31% | 1.68% | 1.00% | 1.20% | 1.35% | 1.87% | 2.14% | 1.45% | 1.52% | 2.87% | 0.92% |
Financials
NVO vs. KKR - Financials Comparison
This section allows you to compare key financial metrics between Novo Nordisk A/S and KKR & Co. Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
NVO vs. KKR - Profitability Comparison
NVO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a gross profit of 83.23B and revenue of 96.82B. Therefore, the gross margin over that period was 86.0%.
KKR - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, KKR & Co. Inc. reported a gross profit of 3.98B and revenue of 4.00B. Therefore, the gross margin over that period was 99.5%.
NVO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported an operating income of 59.62B and revenue of 96.82B, resulting in an operating margin of 61.6%.
KKR - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, KKR & Co. Inc. reported an operating income of 205.35M and revenue of 4.00B, resulting in an operating margin of 5.1%.
NVO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a net income of 48.56B and revenue of 96.82B, resulting in a net margin of 50.2%.
KKR - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, KKR & Co. Inc. reported a net income of 405.23M and revenue of 4.00B, resulting in a net margin of 10.1%.
Frequently Asked Questions
NVO and KKR have a correlation of 0.28, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NVO has higher volatility (11.68%) compared to KKR (10.34%). In terms of maximum drawdown, NVO dropped -74.70% vs KKR's -53.10%.
NVO currently has the higher Sharpe Ratio (-0.51 vs -0.90), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NVO and KKR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer